Norlase is an ophthalmic laser manufacturer specializing in laser technology for the treatment of retinal and glaucoma disorders.
Norlase has raised $20.9M in total funding. The most recent round was Debt Financing. The last funding was announced in February 2025.
Norlase's investors include European Investment Bank, EISMEA, West Hill Capital, Nordic Secondary Fund.
Norlase is headquartered in Ballerup, Denmark.
Norlase is an ophthalmic laser manufacturer specializing in laser technology for the treatment of retinal and glaucoma disorders.
Norlase is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Norlase — Funding & Investors." VCBacked, February 27, 2025, https://www.vcbacked.co/company/norlase. Accessed July 19, 2026.
VCBacked. (2025). Norlase — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/norlase
{{cite web |title=Norlase — Funding & Investors |url=https://www.vcbacked.co/company/norlase |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated